“We translate big data into even bigger, healthier and safer outcomes.” -Almut Wintersein, R.Ph., Ph.D., FISPE
What is POP all about?
POP is a hybrid graduate program that combines independent problem solving and establishing methodological skills. From day one students are involved in active research programs alongside their rigorous coursework to give them the skills to succeed.
What is Pharmacoepidemiology?
Pharmacoepidemiology is the study of drugs, and drug effects, within a population after it has been approved. Pharmacoepidemiology research uses real world data to study a large range patients with a variety of characteristics to help find rare side affects.
Areas of Specialization
Each area focuses on certain competencies, which are met with a focused selection of course work and research experiences. However, students will have exposure to all areas of specialization through exchange with faculty and other students, joined seminars and journal clubs, and shared core didactic course work. All areas across disciplinary boundaries and many faculty are engaged in several areas of concentration.
Some students have concrete ideas about their specialty before they join our graduate program, but some do not or gain a better understanding after they have had more in-depth exposure. The selection of a concentration area should be based upon individual student interests and future career and research goals.
Applies epidemiologic reasoning, methods, and knowledge to studies that examine the safety, effectiveness, and quality of drugs in human populations as well as healthcare systems that impact medication use. Examples of areas of research interest include drug safety, comparative effectiveness, drug utilization and quality measures for medication safety and appropriateness.
Assesses the value (clinical and economic) of pharmaceutical products and related services in the delivery of healthcare. It aims to provide patients, providers, and payers with evidence to inform decision making. Important research areas include economic evaluations, budget impact analysis, multi-criteria decision analysis, and policy evaluations related to drug formulary, reimbursement and pricing.
Establishes the ability to evaluate the quality of medication use and medication use systems, to develop target interventions for identified quality deficits, and to evaluate the safety and effectiveness of such interventions. Examples of research include the development and validation of quality measures, or the implementation and evaluation of quality improvement programs.
What Our Students are saying
“We are trying to investigate the safety and effectivities of medications and biologics, which are already in the market to ensure that the patient are taking the medication to benefit their health conditions.”
– YoonYoung Choi
“We see ourselves at the end of the continuum of drug development, but a very important one because once the drug gets out on the market, the job is not done.”
– Juan Hincapie-Castillo
Students are admitted into the Ph.D. and residential M.S. programs in the fall semester. Review of applications begins December 1 and ends April 1. Decisions on first round interviews and nominations for fellowship are finalized by January 15; thus completing your application before December 1 is strongly encouraged. The online M.S. programs offer rolling admission.
Stem and POP: The University of Florida College of Pharmacy Department of Pharmaceutical Outcomes and Policy offers a STEM-designated Ph.D. program in Pharmaceutical Sciences with a concentration in Pharmaceutical Outcomes & Policy Research (POP Ph.D.). This program has the Department of Education’s Classification of Instructional Program, or CIP, taxonomy code CIP 51.2010. This code denotes Pharmaceutical Sciences and is a STEM-designated degree program.